MedX Health Corp (CVE:MDX – Get Free Report)’s stock price hit a new 52-week high on Thursday . The company traded as high as C$0.10 and last traded at C$0.10, with a volume of 41500 shares. The stock had previously closed at C$0.09.
MedX Health Price Performance
The company has a market capitalization of C$26.20 million, a price-to-earnings ratio of -3.33 and a beta of 1.21. The stock’s fifty day simple moving average is C$0.06 and its two-hundred day simple moving average is C$0.06.
MedX Health (CVE:MDX – Get Free Report) last issued its earnings results on Wednesday, March 6th. The company reported C($0.53) earnings per share for the quarter. The business had revenue of C$26.41 million for the quarter. On average, sell-side analysts predict that MedX Health Corp will post 0.0029191 EPS for the current year.
MedX Health Company Profile
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market.
Further Reading
- Five stocks we like better than MedX Health
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- MarketBeat Week in Review – 4/22 – 4/26
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- 3 Stocks Leading the U.S. Agriculture Comeback
- Financial Services Stocks Investing
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for MedX Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedX Health and related companies with MarketBeat.com's FREE daily email newsletter.
